Thanks to the GAVI Alliance, the poorest countries will now have access to a sustainable supply of HPV vaccines for as low as US$ 4.50 per dose. The same vaccines can cost more than $100 in developed countries and the previous lowest public sector price was $13 per dose.
HPV vaccines are available in the routine immunisation programmes of mostly high-income countries. And yet of the 275,000 women in the world who die of cervical cancer every year, more than 85% are in low-income countries where access to cancer screening and treatment services is often lacking. Worldwide, cervical cancer is second most common and the fifth deadliest cancer in women. It affects about 16 per 100,000 women per year and kills about 9 per 100,000 per year
Safe and effective human papillomavirus (HPV) vaccines protect against HPV types 16 and 18 which cause about 70% of cervical cancer cases.
Cervical cancer is a leading cause of cancer deaths among women in GAVI-eligible countries.
The Gardasil vaccine also helps protect girls and young women ages 9 to 26 against approximately 70% of vaginal cancer cases and up to 50% of vulvar cancer cases.